SmartKem, Inc. (SMTK) - Q3 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. SmartKem, Inc. is a development-stage company focused on organic thin-film transistors (OTFTs) and TRUFLEX® liquid semiconductor polymers for next-generation display technologies. The company operates primarily from Manchester, UK, with prototyping facilities in the UK and Taiwan. As of the filing date, the company is classified as a smaller reporting company and an emerging growth company.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|
| Revenue | $0 | $40,000 | $27,000 |
| Net Loss | $(2.84) million | $(7.64) million | $(7.10) million |
| Operating Expenses | $3.13 million | $8.80 million | $8.32 million |
| Cash and Equivalents (End of Period) | $1.78 million | $1.78 million | $11.21 million |
| Net Cash Used in Operating Activities | N/A | $(7.01) million | $(5.62) million |
| Total Assets | $4.31 million | $4.31 million | $11.27 million (Dec 31, 2023) |
| Accumulated Deficit | $(109.80) million | $(109.80) million | $(95.07) million (Dec 31, 2023) |
Material Changes vs. Prior Period
- Revenue: The company reported zero revenue for Q3 2024, compared to $3,000 in Q3 2023. YTD revenue increased slightly to $40,000 from $27,000 in the prior year, derived from sales of OTFT backplanes and materials for customer assessment.
- Operating Expenses: Total operating expenses increased by approximately $0.48 million YTD compared to 2023. This was driven by a $0.76 million increase in Selling, General, and Administrative (SG&A) expenses, primarily due to personnel costs and professional fees related to the Nasdaq uplisting and business development. R&D expenses decreased slightly by $0.17 million YTD.
- Liquidity: Cash and cash equivalents declined significantly from $8.84 million at year-end 2023 to $1.78 million at September 30, 2024, reflecting a net cash burn of $7.01 million from operations.
- Warrant Liability: The company reclassified its warrant liability from a liability to equity in May 2024 following its uplisting to the Nasdaq Capital Market, eliminating the $1.37 million warrant liability recorded at the end of 2023.
Outlook, Risks, and Management Commentary
- Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern. With only $1.78 million in cash and a burn rate of approximately $7 million over nine months, the company states its current resources are insufficient to fund operations for the next 12 months. Additional capital is required to continue R&D and commercialization.
- Capital Strategy: The company plans to finance future operations through equity offerings, debt financings, collaborations, or strategic alliances. Management notes that raising equity will likely result in dilution to existing shareholders.
- Material Weakness: A material weakness in internal control over financial reporting was identified in Q1 2024 related to the complex accounting of a Consent, Conversion, and Amendment Agreement. Management is implementing remediation measures but notes disclosure controls were not effective as of September 30, 2024.
- Geographic Risk: The company highlights risks associated with partners and potential customers located in Taiwan, including exposure to natural disasters, political unrest, and supply chain disruptions.
- Listing Requirements: The company faces risks regarding compliance with Nasdaq continued listing requirements, specifically the $1.00 minimum bid price and $2.5 million minimum stockholders' equity.
Investor Verification Checklist
- Cash Runway: Verify the timeline for the next capital raise given the $1.78 million cash balance and $7.0 million YTD operating cash burn.
- Revenue Pipeline: Assess the status of customer assessments and the timeline for commercial revenue generation, as current revenue is negligible.
- Internal Controls: Monitor the progress of remediation for the identified material weakness in financial reporting.
- Dilution Risk: Review the terms of any upcoming equity offerings, noting the existing overhang of warrants (approx. 2.5 million) and preferred stock conversion rights.
- Nasdaq Compliance: Track the stock price relative to the $1.00 minimum bid price requirement to assess delisting risk.